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Background
The improvement of in vitro maturation (IVM) proto-
cols through the supplementation with different mole-
cules has become an alternative to increase the culture
medium efficiency. Tretinoin (TTN, all-trans retinoic
acid, ATRA), is an active metabolite of vitamin A [1],
that mediates cell proliferation, cell differentiation, and
embryonic development process. In in vitro production
embryos systems, TTN acts improving cytoplasmic
maturation process in oocytes, developmental compe-
tence in early embryos, and quality in blastocysts [2].
Studies have been demonstrated the presence of a, b
and g subtypes of retinoic acid receptors (RARa, RARb,
RARg) for TTN in oocyte, hatched blastocysts, and
cumulus cells [3]. This molecule can also be used for
treatment of skin disorders and for anti-tumor treat-
ment, so researchers have been associated TTN with
polymeric nanoparticles to protect it from degradation
and to improve its chemical stability and efficacy [4].
The aim of present study was to test the concentration-
dependent effect of supplementation of free tretinoin
(TTN) and tretinoin-loaded lipid-core nanocapsules
(TTN-LNC) in bovine in vitro maturation media, and its
influence in reactive oxygen species (ROS) production
in two-to four-cell stage embryos. In conclusion, treti-
noin- loaded lipid-core nanocapsules added in in vitro
maturation media highly protects embryos at early stage
of development against oxidative stress.
Methods
The experimental groups were established, and
cumulus-oocyte complexes (COCs) were matured in
oocyte in vitro maturation medium supplemented with
0.25, 0.5 and 1 μM of TTN-LNC or TTN. Control
groups of COCs matured without treatment and treated
only with blank lipid-core-nanocapsules (LNC) were
also examined. The oocytes were in vitro fertilized in
order to evaluate the ROS levels in embryos produced
by the different treatments. The ROS formation was
evaluated in two-to four-cell stage embryos as previously
described [5] with some modifications.
Results and conclusions
ROS production was lower in embryos derived from
oocytes matured in the presence of TTN or TTN-LNC.
Both treatments TTN and TTN-LCNC protect the cell
more effectively against oxidative damage reducing the
ROS production. A significant reduction (p < 0.05) in
ROS production was detected in the presence of TTN-
LCNC compared with controls. There was no difference
between the concentrations in TTN and TTN-LNC
groups. Tretinoin-loaded lipid-core nanocapsules offers
an increased protection against oxidative stress in
embryos produced in vitro. The studies at the molecular
level using oocyte competence markers are alternatives
to clarify the function of lipid-core nanocapsules in in
vitro maturation and in embryonic development.
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